Recent advances in the therapeutic application of short-chain fatty acids (SCFAs): An updated review
Abdur Rauf, Anees Ahmed Khalil, Ubaid-ur- Rahman, Ahood Khalid, Saima Naz, Mohammad Ali Shariati, Максим Ребезов, Ewaldo Zavala Urtecho, Ricardo Diego Duarte Galhardo de Albuquerque, Sirajudheen Anwar, Abdulwahab Alamri, Ramesh Kumar Saini, Kannan R. R. Rengasamy
Abstract
Over the past decade, the gut microbiota has emerged as an important frontier in understanding the human body's homeostasis and the development of diseases. Gut flora in human beings regulates various metabolic functionalities, including enzymes, amino acid synthesis, bio-transformation of bile acid, fermentation of non-digestible carbohydrates (NDCs), generation of indoles and polyamines (PAs), and production of short-chain fatty acids (SCFAs). Among all the metabolites produced by gut microbiota, SCFAs, the final product of fermentation of dietary fibers by gut microbiota, receive lots of attention from scientists due to their pharmacological and physiological characteristics. However, the molecular mechanisms underlying the role of SCFAs in the interaction between diet, gut microbiota, and host energy metabolism is still needed in-depth research. This review highlights the recent biotechnological advances in applying SCFAs as important metabolites to treat various diseases and maintain colonic health.